CONTRASTING EFFECTS OF PROPIONATE AND PROPIONYL-L-CARNITINE ON ENERGY-LINKED PROCESSES IN ISCHEMIC HEARTS

被引:22
作者
DILISA, F [1 ]
MENABO, R [1 ]
BARBATO, R [1 ]
SILIPRANDI, N [1 ]
机构
[1] CNR,CTR STUDIO FISIOL MITOCONDRIALE,I-35121 PADUA,ITALY
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 267卷 / 02期
关键词
ISCHEMIA; MITOCHONDRIA; L-CARNITINE; COENZYME A;
D O I
10.1152/ajpheart.1994.267.2.H455
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Propionyl-L-carnitine, unlike L-carnitine, is known to improve myocardial function and metabolism altered during the course of ischemia-reperfusion. In this study, the effect of propionyl-L-carnitine has been compared with that of propionate and carnitine on the performance of rat hearts perfused with a glucose-containing medium either under normoxia, ischemia, or postischemic reperfusion. In the postischemic phase, contractile parameters were partially restored both in the control and in the propionate plus carnitine-treated hearts, were markedly impaired by propionate, and were fully recovered by propionyl-L-carnitine. In addition, propionyl-L-carnitine, but not propionate, reduced the functional decay of mitochondria prepared from the ischemic hearts. Even in normoxic conditions propionate, unlike propionyl-L-carnitine, caused a drastic reduction of free CoA and L-carnitine. The concomitant increase in lactate production and decrease in ATP content might be explained by the inhibition of pyruvate dehydrogenase caused by the accumulation of propionyl-CoA. Indeed, when pyruvate was the only oxidizable substrate, propionate induced a gradual decrease in developed pressure, which was largely prevented by L-carnitine. The protective effect of propionyl-L-carnitine may be a consequence of the anaplerotic utilization of propionate in the presence of an optimal amount of ATP and free L-carnitine.
引用
收藏
页码:H455 / H461
页数:7
相关论文
共 28 条
[1]   EFFECTS OF PROPIONATE ON MECHANICAL AND METABOLIC PERFORMANCE IN AEROBIC RAT HEARTS [J].
BOLUKOGLU, H ;
NELLIS, SH ;
LIEDTKE, AJ .
CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 :37-44
[2]   SUPERIORITY OF L-PROPIONYLCARNITINE VS L-CARNITINE IN IMPROVING WALKING CAPACITY IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE - AN ACUTE, INTRAVENOUS, DOUBLE-BLIND, CROSS-OVER STUDY [J].
BREVETTI, G ;
PERNA, S ;
SABBA, C ;
ROSSINI, A ;
DIUCCIO, VS ;
BERARDI, E ;
GODI, L .
EUROPEAN HEART JOURNAL, 1992, 13 (02) :251-255
[3]   MECHANISM OF ANTIKETOGENIC ACTION OF PROPIONATE AND SUCCINATE IN ISOLATED RAT-LIVER MITOCHONDRIA [J].
CIMAN, M ;
ROSSI, CR ;
SILIPRAN.N .
FEBS LETTERS, 1972, 22 (01) :8-&
[4]  
DEGROOT MJM, 1992, MOL CELL BIOCHEM, V118, P1
[5]  
DILISA F, 1993, CARDIOVASC RES, V27, P1840
[6]  
DILISA F, 1989, MOL CELL BIOCHEM, V88, P169
[7]  
DILISA F, 1992, CIRCULATION, V86, P35
[8]   PROLONGED PROPIONYL-L-CARNITINE PRETREATMENT OF RABBIT - BIOCHEMICAL, HEMODYNAMIC AND ELECTROPHYSIOLOGICAL EFFECTS ON MYOCARDIUM [J].
FERRARI, R ;
DILISA, F ;
DEJONG, JW ;
CECONI, C ;
PASINI, E ;
BARBATO, R ;
MENABO, R ;
BARBIERI, M ;
CERBAI, E ;
MUGELLI, A .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 (03) :219-232
[9]  
FERRARI R, 1989, MOL CELL BIOCHEM, V88, P161
[10]  
Gutmann I., 1974, METHOD ENZYMAT AN, P1464